Amphotericin B-induced nephrogenic diabetes insipidus in a case of cryptococcemia

Internal Medicine

Volumn 44, Issue 5, 2005, Pages 458-461

  Fujita, Yukio ^a   Kasahara, Kei ^a   Uno, Kenji ^a   Konishi, Mitsuru ^a   Maeda, Koichi ^a   Yoshimoto, Eiichiro ^a   Murakawa, Koichi ^a   Mikasa, Keiichi ^a   Amano, Itsuto ^a   Morii, Takeshi ^a   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Amphotericin B; Cryptococcemia; Nephrogenic diabetes insipidus

Indexed keywords

AMPHOTERICIN B; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFPIROME; CYCLOPHOSPHAMIDE; ETOPOSIDE; ITRACONAZOLE; MERCAPTOPURINE; MEROPENEM; POTASSIUM;

AGED; ARTICLE; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; FLUID BALANCE; FLUID THERAPY; HUMAN; HYPOKALEMIA; KIDNEY TUBULE ACIDOSIS; LYMPHOMA; NEPHROGENIC DIABETES INSIPIDUS; PANCYTOPENIA; POLYURIA; POTASSIUM BLOOD LEVEL;

6-MERCAPTOPURINE; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ANTIMETABOLITES, ANTINEOPLASTIC; BACTEREMIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIABETES INSIPIDUS, NEPHROGENIC; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 21244486288     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.458     Document Type: Article

References (10)

1. Deray G. Amphotericin B nephrotoxicity. J Antimicrob Chemother 49 Suppl 1: 37-41, 2002.
2. Sawaya BP, Briggs JP, Schnermann J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol 6: 154-164, 2001.
3. Hopp L, Bernardi J, Reeves G. Amphotericin B-induced partial nephrogenic diabetes insipidus in a child. Pediatr Nephrol 16: 594-597, 2001.
4. Barbour GL, Straub KD, O'Neal BL, Leatherman YW. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Arch Intern Med 139: 86-88, 1979.
5. Smith OP, Gale R, Hamon M, McWhinney P, Prentice HG. Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart. Bone Marrow Transplant 13: 107-108, 1994.
6. Spath-Schwalbe E, Koschuth A, Dietzmann A, Schanz J, Possinger K. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus. Clin Infect Dis 28: 680-691, 1999.
7. Robertson GL. Differential diagnosis of polyuria. Annu Rev Med 39: 425-442, 1988.
8. McCurdy DK, Frederic M, Elkinton JR. Renal tubular acidosis due to amphotericin B. N Engl J Med 278: 124-130, 1968.
9. Höhler T, Teuber G, Wanitschke R, Meyer zum Büschenfeld KH. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus. Clin Investig 72: 769-771, 1994.
10. Canada TW, Weavind LM, Augustin KM. Possible liposomal amphotericin B-induced nephrogenic diabetes insipidus. Ann Pharmacother 37: 70-73, 2003.